Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Mesa Laboratories (MLAB) EBIT: 2010-2025

Historic EBIT for Mesa Laboratories (MLAB) over the last 16 years, with Sep 2025 value amounting to $4.7 million.

  • Mesa Laboratories' EBIT rose 34.66% to $4.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.0 million, marking a year-over-year increase of 105.73%. This contributed to the annual value of $16.3 million for FY2025, which is 106.00% up from last year.
  • According to the latest figures from Q3 2025, Mesa Laboratories' EBIT is $4.7 million, which was up 54.18% from $3.1 million recorded in Q2 2025.
  • In the past 5 years, Mesa Laboratories' EBIT ranged from a high of $5.8 million in Q4 2024 and a low of -$271.3 million during Q1 2024.
  • Over the past 3 years, Mesa Laboratories' median EBIT value was $1.5 million (recorded in 2025), while the average stood at -$22.5 million.
  • Examining YoY changes over the last 5 years, Mesa Laboratories' EBIT showed a top increase of 8,725.37% in 2024 and a maximum decrease of 52,572.73% in 2024.
  • Quarterly analysis of 5 years shows Mesa Laboratories' EBIT stood at -$2.5 million in 2021, then soared by 235.43% to $3.4 million in 2022, then plummeted by 101.97% to -$67,000 in 2023, then soared by 8,725.37% to $5.8 million in 2024, then skyrocketed by 34.66% to $4.7 million in 2025.
  • Its EBIT was $4.7 million in Q3 2025, compared to $3.1 million in Q2 2025 and $1.5 million in Q1 2025.